NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

  News | News By Subject | News by Disease News By Date | Search News
   

CryoPort, Inc. Data Logger Providing Proof of Temperature Integrity During Shipping
8/26/2009

LAKE FOREST, CA--(Marketwire - August 26, 2009) - CryoPort Systems, Inc. (OTCBB: CYRX) today announced successful testing and implementation of an automated data logger that tracks the internal and external sample temperatures.

The data logger provides another enhancement to the CryoPort Express™ Shipping System that already has a significant advantage with its long holding times over short term dry ice shipments. By providing the temperature data during transport, customers can be assured that their samples will have arrived with constant temperatures during shipment. In addition, the long holding time of the CryoPort Express shipper of 10+ days of frozen integrity give this innovative solution a significant advantage of the standard today of dry ice.

Larry Stambaugh, CEO of CryoPort, stated, "We have been working with a well known biotechnology company on the application of the data logger and they have been extremely pleased with the results of its use. The ease and utility of this addition is a major improvement in the frozen shipping market."

Bret Bollinger, VP of Operations, stated, "The data logger provides us a unique tool that takes the safety and security of shipments to the next level. Customers will no longer have to rely on potentially inaccurate data from probes placed at several locations in a dry ice box. We believe that the integrity of our shipments are well maintained and can be proven."

About CryoPort, Inc.

CryoPort (www.cryoport.com) is commercializing proprietary, technology-driven shipping products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the clinical testing, research and end user deliver of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

SAFE HARBOR

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


CONTACT:
STUART FINE
CARPE DM, INC
908-469-1788



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES